08:48 AM EDT, 03/14/2024 (MT Newswires) -- Curaleaf International, part of Curaleaf Holdings ( CURLF ) and one of Europe's largest vertically integrated cannabis companies, that saw its shares gain 3.4% yeterday, said Thursday it is expanding into the Czech Republic, a new market for the company, through a new supply agreement with Astrasana Pharma s.r.o.

According to a statement, the partnership with Astrasana will see Curaleaf International's EU-GMP flower made available to patients via Pilulka Pharmacy, a healthcare provider in the region.

Juan Pablo Martinez, Head of Curaleaf International, in the statement said, "Our partnership with Astrasana Pharma s.r.o. signifies another step forward in the growing European medical cannabis market. By working together, we aim to enhance access to high-quality medical cannabis in the Czech Republic. Amidst increasing demand for medical cannabis in Europe, this collaboration highlights our dedication to providing reliable products and driving progress in healthcare. Together, we're facilitating patient access and contributing to the evolution of the medicinal cannabis industry."